Home Cascadian Therapeutics

Cascadian Therapeutics

acquired
IPO Delisting
Developer of Synthetic Vaccines and Targeted Small Molecule Drugs

Basic Information

Cascadian Therapeutics is a clinical-stage biopharmaceutical company primarily focused on the development of therapeutic products for the treatment of cancer. The company aims to develop and commercialize novel synthetic vaccines and targeted small molecules to enhance the treatment potential and quality of life for cancer patients.
Cascadian Therapeutics, Inc.
Seattle,Washington,United States of America
51~100 people
January 01, 1985
--
bd@oncothyreon.com